NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
Estimated value
—
Awarded value
£25.9m
Awarded 25 Nov 2025
Suppliers
8
3 SME
Lots
1
1 awarded
Published
26 Nov 2025
Other contracts from NHS England· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| Matrix - Desk Booking System | call off | £105k | 08 May 2026 |
| Telephony 0300 Numbers Renewal (Gamma) 2026 - 2028 | call off | £17k | 08 May 2026 |
| ID&V Checking Service | contract | £150k | 08 May 2026 |
| Xerox Managed Print renewal 26/27 | call off | £127k | 08 May 2026 |
| Manage Engine ServiceDesk Plus Licences | call off | £29k | 08 May 2026 |
| Ccube EDRMS C302203 Annual Maintenance and Support 2025 - 2026 | contract | £105k | 08 May 2026 |
| Clinicals Run Maintain Transform | call off | £38.0m | 10 Apr 2026 |
| Specialised Pharmaceutical Logistics and Warehouse Services for Vaccination & Immunisation Programmes | contract | — | 07 Apr 2026 |
| NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives | contract | — | 07 Apr 2026 |
| CPIT System Integration to NHSE RAVS | contract | £500k | 01 Apr 2026 |
Other contracts awarded to ZENTIVA PHARMA UK LIMITED· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS National Branded Interim - 1 June 2026 | contract | — | 22 May 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | contract | — | 01 May 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | contract | — | 24 Apr 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | contract | — | 25 Feb 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | contract | — | 30 Jan 2026 |
| Project/Contract NHS National Framework for Denosumab Injection | contract | — | 02 Oct 2025 |
| Proprietary Drugs | contract | — | 28 Jul 2025 |
| NHS National Framework for Transition products (Nilotinib and Ticagrelor) | contract | — | 11 Jul 2025 |
| NHS National Framework for Transition products (Nilotinib and Ticagrelor) | contract | — | 11 Jul 2025 |